SCHEMBL880422

SCHEMBL880422

BC(=O)C1=C(C)NC(=O)CC1c1cccnc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.44
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 4/20 0.43
GAA P10253 4/20 0.43
HPGD P15428 3/20 0.43
CASP1 P29466 3/20 0.43
CASP7 P55210 3/20 0.43
HSD17B10 Q99714 2/20 0.43
GLA P06280 1/20 0.42
GPBAR1 Q8TDU6 3/20 0.41
TP53 P04637 1/20 0.41
RPS6KB1 P23443 2/20 0.40
ROCK1 Q13464 2/20 0.40
RPS6KA1 Q15418 2/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13522409 0.85 HTT (0.64) MAPTSMN1; SMN2HTTKDM4EALDH1A1
SCHEMBL880405 0.84 HTT (0.54) LMNAHTTGAAGPBAR1TP53
SCHEMBL13522411 0.69 HTT (0.76) LMNAHTTKDM4EGAAHPGD
SCHEMBL880259 0.69 IDO1 (0.60) LMNAGAAHSD17B10GPBAR1TP53
SCHEMBL14029127 0.69 HTT (0.67) LMNAHTTGAAHSD17B10GPBAR1
SCHEMBL9401812 0.68 CACNA1B (0.65) MAPTKDM4EALDH1A1GAAHPGD
SCHEMBL880375 0.68 HTT (0.78) LMNAHTTKDM4EALDH1A1GAA
SCHEMBL17478072 0.67 LMNA (0.49) LMNAHTTGPBAR1TP53RPS6KB1
SCHEMBL156842 0.66 CHRNB2 (0.56) MAPTSMN1; SMN2LMNAKDM4EALDH1A1
SCHEMBL10280605 0.66 TP53 (0.64) MAPTSMN1; SMN2LMNAHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2433634-A2 Compounds, compositions and methods of inhibiting a-synuclein toxicity The Whitehead Institute for Biomedical Research (US) 2012-03-28 EP disclosed